Compounds > bupranolol

bupranolol and carazolol

bupranolol has been researched along with carazolol in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guillaume, JL; Méjean, A; Strosberg, AD1
Gerhardt, CC; Gros, J; Issad, T; Strosberg, AD1

Other Studies

2 other study(ies) available for bupranolol and carazolol

ArticleYear
Carazolol: a potent, selective beta 3-adrenoceptor agonist.
    European journal of pharmacology, 1995, Nov-30, Volume: 291, Issue:3

    Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Binding, Competitive; Cells, Cultured; CHO Cells; Cricetinae; Dithiothreitol; Lipolysis; Propanolamines; Receptors, Adrenergic, beta

1995
Stimulation of the extracellular signal-regulated kinase 1/2 pathway by human beta-3 adrenergic receptor: new pharmacological profile and mechanism of activation.
    Molecular pharmacology, 1999, Volume: 55, Issue:2

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Calcium-Calmodulin-Dependent Protein Kinases; CHO Cells; Colforsin; Cricetinae; Dioxoles; Enzyme Activation; Epinephrine; Ethanolamines; Humans; Insulin; Isoproterenol; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Norepinephrine; Phentolamine; Prazosin; Propanolamines; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3; Signal Transduction; Yohimbine

1999